Researchers in the UK have developed a high-throughput standardizable assay that accurately detects T cell responses to infection with severe acute respiratory syndrome coronavirus 2
Read more
Home » SARS-CoV-2 »
A research group of the Department of Pharmacy and Biotechnology of the University of Bologna analyzed more than one million SARS-CoV-2 genome sequences. This analysis
Read more
In January 2020, the first complete severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genome sequence was deposited to GenBank. Since then, the amount of new genome
Read more
Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and showing promise. The team, led
Read more
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity is not associated with low vitamin D levels, according to a study published online May 19 in
Read more
The virostatic agent remdesivir was developed to disrupt an important step in the propagation of RNA viruses, to which SARS-CoV-2 also belongs: the reproduction of
Read more
Research by scientists at the University of Texas at Austin, the Santa Fe Institute, and Fractal Therapeutics suggests infection rates in the surrounding community are
Read more
A new study, released as a preprint on the medRxiv* server, adds to the sum of evidence that children do not play a key role
Read more
A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral
Read more
A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern—including B.1.1.7, a variant first identified
Read more